Publicaciones en las que colabora con Elvira Roda Recalde (22)

2024

  1. Development and characterization of a non-human primate model of disseminated synucleinopathy

    Frontiers in Neuroanatomy, Vol. 18

2023

  1. Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates

    Brain : a journal of neurology, Vol. 146, Núm. 12, pp. 5000-5014

  2. Preferential expression of SCN1A in GABAergic neurons improves survival and epileptic phenotype in a mouse model of Dravet syndrome

    Journal of Molecular Medicine, Vol. 101, Núm. 12, pp. 1587-1601

2022

  1. Adeno-Associated Viral Vectors as Versatile Tools for Neurological Disorders: Focus on Delivery Routes and Therapeutic Perspectives

    Biomedicines, Vol. 10, Núm. 4

2021

  1. Adeno-associated viral vectors as versatile tools for parkinson’s research, both for disease modeling purposes and for therapeutic uses

    International Journal of Molecular Sciences, Vol. 22, Núm. 12

  2. Glucocerebrosidase gene therapy induces alpha-synuclein clearance and neuroprotection of midbrain dopaminergic neurons in mice and macaques

    International Journal of Molecular Sciences, Vol. 22, Núm. 9

2020

  1. Expression of GPR55 and either cannabinoid CB1 or CB2 heteroreceptor complexes in the caudate, putamen, and accumbens nuclei of control, parkinsonian, and dyskinetic non-human primates

    Brain Structure and Function, Vol. 225, Núm. 7, pp. 2153-2164

  2. Expression of cannabinoid CB1R–GPR55 heteromers in neuronal subtypes of the Macaca fascicularis striatum

    Annals of the New York Academy of Sciences, Vol. 1475, Núm. 1, pp. 34-42

2018

  1. Gene therapy approaches in the non-human primate model of Parkinson’s disease

    Journal of Neural Transmission, Vol. 125, Núm. 3, pp. 575-589

  2. Glucocerebrosidase expression patterns in the non-human primate brain

    Brain Structure and Function, Vol. 223, Núm. 1, pp. 343-355

2017

  1. Neurochemical evidence supporting dopamine D1–D2 receptor heteromers in the striatum of the long-tailed macaque: changes following dopaminergic manipulation

    Brain Structure and Function, Vol. 222, Núm. 4, pp. 1767-1784

2015

  1. Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism

    Brain Structure and Function, Vol. 220, Núm. 5, pp. 2721-2738

2014

  1. CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum

    Experimental Neurology, Vol. 261, pp. 44-52

  2. Calbindin content and differential vulnerability of midbrain efferent dopaminergic neurons in macaques

    Frontiers in Neuroanatomy, Vol. 8, Núm. DEC

2012

  1. Unmasking adenosine 2A receptors (A2ARs) in monkey basal ganglia output neurons using cholera toxin subunit B (CTB)

    Neurobiology of Disease, Vol. 47, Núm. 3, pp. 347-357

2011

  1. Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis

    Journal of Psychopharmacology, Vol. 25, Núm. 1, pp. 97-104

  2. Glutamatergic and cholinergic pedunculopontine neurons innervate the thalamic parafascicular nucleus in rats: Changes following experimental parkinsonism

    Brain Structure and Function, Vol. 216, Núm. 4, pp. 319-330

  3. Pallidothalamic-projecting neurons in Macaca fascicularis co-express GABAergic and glutamatergic markers as seen in control, MPTP-treated and dyskinetic monkeys

    Brain Structure and Function, Vol. 216, Núm. 4, pp. 371-386

2010

  1. A direct projection from the subthalamic nucleus to the ventral thalamus in monkeys

    Neurobiology of Disease, Vol. 39, Núm. 3, pp. 381-392

  2. Neuroanatomical tracing combined with in situ hybridization: Analysis of gene expression patterns within brain circuits of interest

    Journal of Neuroscience Methods, Vol. 194, Núm. 1, pp. 28-33